Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Leboeuf AA"'
Autor:
Diak IL; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. Ida-Lina.Diak@fda.hhs.gov., Swank K; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., McCartan K; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Beganovic M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Kidd J; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Gada N; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Kapoor R; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Wolf L; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Kangas L; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Wyeth J; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Salvatore T; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Fanari M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., LeBoeuf AA; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Mishra P; Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Blum MD; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Dal Pan G; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Drug safety [Drug Saf] 2023 Feb; Vol. 46 (2), pp. 145-155. Date of Electronic Publication: 2022 Dec 02.
Autor:
Choi SH; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Stephanie.Choi@fda.hhs.gov., Wang Y; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Conti DS; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Raney SG; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Delvadia R; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Leboeuf AA; Office of Generic Drug Policy, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Witzmann K; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2018 Jun 15; Vol. 544 (2), pp. 443-454. Date of Electronic Publication: 2017 Nov 21.
Autor:
Chitnis K; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi, 38677, USA., Narala N; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi, 38677, USA., Vemula SK; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi, 38677, USA., Narala S; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi, 38677, USA., Munnangi S; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi, 38677, USA., Repka MA; Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi, 38677, USA. marepka@olemiss.edu.; Pii Center for Pharmaceutical Technology, The University of Mississippi, University, Mississippi, 38677, USA. marepka@olemiss.edu.
Publikováno v:
AAPS PharmSciTech [AAPS PharmSciTech] 2024 Dec 17; Vol. 26 (1), pp. 16. Date of Electronic Publication: 2024 Dec 17.
Autor:
Kumar, Sandeep1 (AUTHOR), Peterson, Timothy R.1 (AUTHOR) timrpeterson@wustl.edu
Publikováno v:
Nutrition & Healthy Aging. 2020, Vol. 5 Issue 4, p239-246. 8p.
Autor:
Faisal Talib, Muhammed Muaz
The focus of this book is to cover the fundamentals, methodological approaches, and diverse applications of smart systems. Smart Systems discusses important topics such as the Internet of Things-enabled smart systems, artificial intelligence, ergonom
Autor:
Monique Elseviers, Björn Wettermark, Tanja Mueller, Ria Benko, Marion Bennie, Katarina Gvozdanovic, Mikael Hoffmann, Irina Iaru, Verica Ivanovska, Sean MacBride-Stewart, Elisabetta Poluzzi, Lisa Pont, Hege Salvesen Blix, Gabriel Sanfelix-Gimeno, Gisbert Selke, Katja Taxis, Ana Tomas Petrovic, Indre Treciokiene, Sabine Vogler
Towards a better understanding of how medicines are used in society Drug Utilization Research (DUR) is a discipline which combines aspects of pharmacotherapy, epidemiology, and health services research into an interdisciplinary set of methods for ana
Autor:
Carla Vitorino
The aim of this book is to provide insights on the methods currently available to holistically support the bioequivalence assessment. The Bioequivalence assessment has become the cornerstone of generic drug approval worldwide, enabling the introducti